Biogen Inc (BIIB)
209.48
+7.02
(+3.46%)
USD |
NASDAQ |
Apr 26, 14:42
Biogen Total Liabilities (Quarterly): 11.35B for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 11.35B |
December 31, 2023 | 12.05B |
September 30, 2023 | 13.71B |
June 30, 2023 | 10.70B |
March 31, 2023 | 10.81B |
December 31, 2022 | 11.17B |
September 30, 2022 | 12.09B |
June 30, 2022 | 13.22B |
March 31, 2022 | 12.39B |
December 31, 2021 | 12.92B |
September 30, 2021 | 12.92B |
June 30, 2021 | 13.26B |
March 31, 2021 | 13.19B |
December 31, 2020 | 13.93B |
September 30, 2020 | 14.19B |
June 30, 2020 | 14.22B |
March 31, 2020 | 13.58B |
December 31, 2019 | 13.90B |
September 30, 2019 | 13.49B |
June 30, 2019 | 13.34B |
March 31, 2019 | 12.62B |
December 31, 2018 | 12.26B |
September 30, 2018 | 11.73B |
June 30, 2018 | 11.70B |
March 31, 2018 | 12.05B |
Date | Value |
---|---|
December 31, 2017 | 11.05B |
September 30, 2017 | 10.22B |
June 30, 2017 | 10.19B |
March 31, 2017 | 9.728B |
December 31, 2016 | 10.75B |
September 30, 2016 | 9.990B |
June 30, 2016 | 10.11B |
March 31, 2016 | 10.35B |
December 31, 2015 | 10.13B |
September 30, 2015 | 10.16B |
June 30, 2015 | 4.186B |
March 31, 2015 | 3.550B |
December 31, 2014 | 3.501B |
September 30, 2014 | 3.273B |
June 30, 2014 | 3.353B |
March 31, 2014 | 3.089B |
December 31, 2013 | 3.242B |
September 30, 2013 | 3.125B |
June 30, 2013 | 2.939B |
March 31, 2013 | 2.825B |
December 31, 2012 | 3.166B |
September 30, 2012 | 2.969B |
June 30, 2012 | 2.892B |
March 31, 2012 | 2.805B |
December 31, 2011 | 2.623B |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
10.70B
Minimum
Jun 2023
14.22B
Maximum
Jun 2020
12.82B
Average
13.20B
Median
Total Liabilities (Quarterly) Benchmarks
Eli Lilly and Co | 53.14B |
Bristol-Myers Squibb Co | 65.67B |
Gilead Sciences Inc | 39.38B |
AbbVie Inc | 124.31B |
Regeneron Pharmaceuticals Inc | 7.107B |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 26.57B |
Shareholders Equity (Quarterly) | 15.21B |
Debt to Equity Ratio | 0.4299 |
Current Ratio | 2.096 |
Net Debt Paydown Yield | -0.17% |